A Gut Microbial Metabolite HYA Ameliorates Adipocyte Hypertrophy by Activating AMP-Activated Protein Kinase
Authors:
- Rino MatsushitaRMRino Matsushita
- Kaori SatoKSKaori Sato
- Kunitoshi UchidaKUKunitoshi Uchida
- Yukiko ImiYIYukiko Imi
- Reina AmanoRAReina Amano
- Nanaho KasaharaNKNanaho Kasahara
- Yuki KitaoYKYuki Kitao
- Yuki OishiYOYuki Oishi
- Honoka KawaaiHKHonoka Kawaai
- Chiaki TomimotoCTChiaki Tomimoto
- Yusei HosokawaYHYusei Hosokawa
- Shigenobu KishinoSKShigenobu Kishino
Open Access
Abstract
Background/Objectives: Metabolites produced by gut microbiota play an important role in the crosstalk between the gut and other organs. Although HYA (10-hydroxy-cis-12-octadecenoic acid), a linoleic acid metabolite produced by lactic acid bacteria represented by Lactobacillus, has been shown to exert physiological effects such as metabolic improvement and anti-inflammation in the host, its direct action on adipose tissue and the mechanism remains unknown. Methods: The effect of HYA administration on adipocyte size in mice fed a high-fat diet was examined. In 3T3-L1 mature adipocytes treated with HYA, the amount of intracellular lipid droplets was evaluated by Oil red O staining, gene expression by real-time qPCR, phosphorylation of AMP-activated protein kinase (AMPK) by immunoblotting, and intracellular Ca2+ concentration with calcium imaging. Results: Administration of HYA, but not linoleic acid, to obese mice fed a high-fat diet significantly reduced adipocyte size. To investigate whether the inhibition of adipocyte hypertrophy by HYA has a direct effect on adipocytes, 3T3-L1 adipocytes were treated with HYA, which significantly decreased the amount of intracellular lipid droplets in these cells. Gene expression analysis by real-time PCR showed decreased expression of genes related to lipogenesis such as FAS and ACC1, and increased expression of CPT1A, which is involved in fatty acid oxidation. Mechanistically, HYA was found to activate AMPK in adipocytes by increasing intracellular Ca2+ concentration. Conclusions: HYA suppresses adipocyte hypertrophy by activating AMPK in adipocytes. HYA may be a potential therapeutic for obesity and related metabolic disorders.Keywords
All Related Versions
Funding Information
- Ono Medical Research Foundation
This publication has 38 references indexed in Scilit:
- Ligands and agonists of the aryl hydrocarbon receptor AhR: Facts and mythsBiochemical Pharmacology, 2023
- Metabolite interactions between host and microbiota during health and disease: Which feeds the other?Biomedicine & Pharmacotherapy, 2023
- Insulin action in adipocytes, adipose remodeling, and systemic effectsCell Metabolism, 2021
- The path toward using microbial metabolites as therapiesEBioMedicine, 2019
- FK506 (tacrolimus) causes pain sensation through the activation of transient receptor potential ankyrin 1 (TRPA1) channelsThe Journal of Physiological Sciences, 2018
- Gut Microbial Fatty Acid Metabolites Reduce Triacylglycerol Levels in HepatocytesLipids, 2015
- Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohortsCancer Causes & Control, 2010
- Role of AMP‐activated protein kinase in the metabolic syndrome and in heart diseaseFEBS Letters, 2007
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- The Deadly QuartetArchives of internal medicine (1960), 1989